TG THERAPEUTICS, INC. Cash and Cash Equivalents
TG THERAPEUTICS, INC. (TGTX) had Cash and Cash Equivalents of $482.57 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-05
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $482.57M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $442.21M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $79.15M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $74.08M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $482.57M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $442.21M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $79.15M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $74.08M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $129.13M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $132.14M 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $179.89M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $195.82M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $82.91M 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $75.48M 10-Q · filed 2025-05-09 | |
| 2023-12-31 | $92.93M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $150.90M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $97.01M 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $61.47M 10-Q · filed 2024-05-06 | |
| 2022-12-31 | $102.30M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $109.86M 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $147.07M 10-Q · filed 2023-08-04 | |
| 2022-03-31 | $185.68M 10-Q · filed 2023-05-08 | |
| 2021-12-31 | $298.89M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $326.51M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $401.71M 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $471.51M 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $553.44M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $254.15M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $260.51M 10-Q · filed 2021-08-06 | |
| 2020-03-31 | $52.05M 10-Q · filed 2021-05-10 | |
| 2019-12-31 | $112.64M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $44.67M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $57.23M 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $64.35M 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $41.96M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $70.72M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $105.67M 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $82.90M 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $56.72M 10-K · filed 2020-03-02 | $56.72M 10-K · filed 2018-03-15 |
| 2017-09-30 | $91.84M 10-Q · filed 2018-11-09 | $91.84M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $77.60M 10-Q · filed 2018-08-09 | $77.60M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $95.64M 10-Q · filed 2018-05-10 | $95.64M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $25.03M 10-K · filed 2019-03-01 | $25.03M 10-K · filed 2017-03-16 |
| 2016-09-30 | $29.16M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $28.58M 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $36.48M 10-Q · filed 2017-05-10 | |
| 2015-12-31 | $55.06M 10-K · filed 2018-03-15 | |
| 2015-09-30 | $65.46M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $60.30M 10-Q · filed 2016-08-09 | |
| 2015-03-31 | $86.00M 10-Q · filed 2016-05-10 | |
| 2014-12-31 | $55.71M 10-K · filed 2018-03-15 | |
| 2014-09-30 | $53.23M 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $37.08M 10-Q · filed 2015-08-10 | |
| 2014-03-31 | $49.60M 10-Q · filed 2015-05-11 | |
| 2013-12-31 | $40.49M 10-K · filed 2017-03-16 | |
| 2013-09-30 | $50.18M 10-Q · filed 2014-11-14 | |
| 2013-06-30 | $13.42M 10-Q · filed 2014-07-24 | |
| 2013-03-31 | $15.19M 10-Q · filed 2014-05-14 | |
| 2012-12-31 | $16.46M 10-K · filed 2016-03-15 | |
| 2012-09-30 | $17.37M 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $20.37M 10-Q · filed 2013-08-09 | |
| 2012-03-31 | $20.92M 10-Q · filed 2013-05-14 | |
| 2011-12-31 | $9.75M 10-K · filed 2014-03-07 | |
| 2011-11-30 | $0.00 10-Q · filed 2014-05-14 | |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 | $212.28K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $0.00 10-Q · filed 2012-11-14 | $492.51K 10-Q/A · filed 2011-09-14 |
| 2011-03-31 | $0.00 10-Q · filed 2012-11-14 | |
| 2010-12-31 | $0.00 10-K · filed 2013-03-21 | $478.67K 10-Q/A · filed 2011-09-14 |
| 2010-09-30 | $1.08M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $1.57M 10-Q/A · filed 2011-09-14 | |
| 2009-12-31 | $0.00 10-K · filed 2013-03-21 | $18.00K 10-Q/A · filed 2011-09-14 |
| 2001-08-05 | $0.00 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |